1. Home
  2. IOVA vs HLF Comparison

IOVA vs HLF Comparison

Compare IOVA & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • HLF
  • Stock Information
  • Founded
  • IOVA 2007
  • HLF 1980
  • Country
  • IOVA United States
  • HLF United States
  • Employees
  • IOVA N/A
  • HLF N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • HLF Other Pharmaceuticals
  • Sector
  • IOVA Health Care
  • HLF Health Care
  • Exchange
  • IOVA Nasdaq
  • HLF Nasdaq
  • Market Cap
  • IOVA 975.1M
  • HLF 877.4M
  • IPO Year
  • IOVA N/A
  • HLF N/A
  • Fundamental
  • Price
  • IOVA $2.31
  • HLF $8.62
  • Analyst Decision
  • IOVA Buy
  • HLF Strong Buy
  • Analyst Count
  • IOVA 11
  • HLF 4
  • Target Price
  • IOVA $11.90
  • HLF $11.50
  • AVG Volume (30 Days)
  • IOVA 10.3M
  • HLF 1.2M
  • Earning Date
  • IOVA 11-06-2025
  • HLF 11-05-2025
  • Dividend Yield
  • IOVA N/A
  • HLF N/A
  • EPS Growth
  • IOVA N/A
  • HLF 285.96
  • EPS
  • IOVA N/A
  • HLF 3.17
  • Revenue
  • IOVA $241,525,000.00
  • HLF $4,928,500,000.00
  • Revenue This Year
  • IOVA $68.14
  • HLF $1.02
  • Revenue Next Year
  • IOVA $56.64
  • HLF $4.52
  • P/E Ratio
  • IOVA N/A
  • HLF $2.77
  • Revenue Growth
  • IOVA 636.99
  • HLF N/A
  • 52 Week Low
  • IOVA $1.64
  • HLF $5.04
  • 52 Week High
  • IOVA $12.51
  • HLF $10.83
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 53.84
  • HLF 44.01
  • Support Level
  • IOVA $2.13
  • HLF $8.51
  • Resistance Level
  • IOVA $2.31
  • HLF $8.85
  • Average True Range (ATR)
  • IOVA 0.13
  • HLF 0.34
  • MACD
  • IOVA 0.02
  • HLF 0.01
  • Stochastic Oscillator
  • IOVA 72.97
  • HLF 44.21

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About HLF Herbalife Ltd.

Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.

Share on Social Networks: